共 49 条
[1]
Siegel RL(2022)Cancer statistics, 2022 CA Cancer J Clin 72 7-33
[2]
Amparo RS(2000)Inflammatory breast carcinoma: pathological or clinical entity? Breast Cancer Res Treat 64 269-273
[3]
Cserni G(2018)Inflammatory breast cancer: The pathologists' perspective Eur J Surg Oncol 44 1128-1134
[4]
Charafe-Jauffret E(2020)Biological subtype, treatment response and outcomes in inflammatory breast cancer using data from the National Cancer Database Br J Surg 107 1033-1041
[5]
van Diest PJ(2011)International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment Ann Oncol 22 515-523
[6]
Kupstas AR(2018)Inflammatory breast cancer: what to know about this unique, aggressive breast cancer Surg Clin North Am 98 787-800
[7]
Dawood S(2015)Inflammatory breast cancer: an overview Crit Rev Oncol Hematol 93 116-126
[8]
Menta A(2005)Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute J Natl Cancer Inst 97 966-975
[9]
van Uden DJ(2022)Incidence, characteristics, and management of central nervous system metastases in patients with inflammatory breast cancer Cancer 128 4085-4094
[10]
Hance KW(2021)Comparison of survival in non-metastatic inflammatory and other T4 breast cancers: a SEER population-based analysis BMC Cancer 21 138-375